‘They said AI saved me’: How South Korea is checking on its older adults
An artificial intelligence-powered call service adopted by cities and counties across South Korea checks on thousands of older adults living alone in isolation or poverty.
Mary Beth Hurt Dies: ‘The Age of Innocence’ & ‘Six Degrees of Separation’ Actress Was 79
Mary Beth Hurt, the actress known for roles in 'The Age of Innocence' and 'Six Degrees of Separation' (both 1993), has died. She was 79.
More than 90% of patients receiving Alzheimer's drug Lecanemab in hospitals across Japan have been able to continue treatment without strong side effects, a group of researchers has said.
https://www.japantimes.co.jp/news/2026/03/25/japan/science-health/alzheimers-drug-lecanemab-safety/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimer039s #drugs #health
Research team confirms safety of Alzheimer's drug Lecanemab
The research team examined data on the health status of 2,672 patients 28 weeks after the start of the treatment.
Chris Hemsworth Was Worried Fans Would “No Longer Believe” Him As Leading Man After Revealing Alzheimers Genetic Predisposition
As Chris Hemsworth lets fans into his family's struggle with Alzheimer's, he's curious how the mental health revelation will impact his career.
Alzheimer's drug hunt learns from cancer fight's multi-target playbook
Just two drugs are widely approved to slow Alzheimer's — Eli Lilly's Kisunla and Leqembi from Eisai and Biogen.
Undeterred by Novo Nordisk failure, scientists weigh GLP-1s as Alzheimer's prevention
In a release scant on details, the Danish drugmaker said Rybelsus did improve some unspecified Alzheimer’s-related biological processes.
Japan’s front-line researchers see bright path ahead for dementia treatment
Four scientists at the forefront of dementia research speak about what kind of future they envision for people with the condition.
Japan approves price cut for Alzheimer's drug Lecanemab
The drug's price will be lowered to ¥97,277 for a 500-milligram bottle starting on Nov. 1.
A Japanese research team has started a final-stage clinical trial to treat familial Alzheimer's disease patients with a drug discovered through induced pluripotent stem (IPS) cells.
https://www.japantimes.co.jp/news/2025/06/04/japan/science-health/alzheimers-ips-drug-trial/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimer039s #ips
Japanese team starts final-stage trial for iPS drug to treat Alzheimer's
Through the trial, which began in May, the team aims to confirm the safety and efficacy of the treatment, with hopes of obtaining regulatory approval.
The Japan Times
Deadline